Press release
Weight Loss Drugs Market Analysis, Size, Growth, Trends And Forecast 2024-2033
Weight Loss Drugs Market Analysis
According to The Business Research Company's, The weight loss drugs market size has grown exponentially in recent years. It will grow from $1.94 billion in 2023 to $2.87 billion in 2024 at a compound annual growth rate (CAGR) of 47.8%. The growth in the historic period can be attributed to increasing obesity rates, lifestyle changes, awareness and education, early diagnosis of medical conditions, rising healthcare expenditure.
The weight loss drugs market size is expected to see exponential growth in the next few years. It will grow to $12.17 billion in 2028 at a compound annual growth rate (CAGR) of 43.5%. The growth in the forecast period can be attributed to increasing geriatric population, social media influence, fitness and wellness trends, cultural perception of beauty, pharmaceutical industry investments. Major trends in the forecast period include technological advancements, focus on non-prescription solutions, personalized medicine, combination therapies, product innovation, post-market surveillance.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/weight-loss-drugs-global-market-report
Market Drivers and Trends:
Increasing obesity rates is expected to propel the growth of the weight loss drugs market going forward. Obesity rate refers to the proportion of individuals in a population who have a body mass index (BMI) equal to or greater than 30. Weight loss drugs are medications used in obesity to help individuals achieve weight loss by either reducing appetite, increasing feelings of fullness, or interfering with the absorption of nutrients For instance, in September 2023, according to the Centers for Disease Control and Prevention, a US-based government organization, adult obesity rates exceeded 35% in 19 states in 2021 and 22 states in 2022. Further, adult obesity prevalence was at or above 35% in 2022. Further, in March 2023, according to the World Obesity Federation, a UK-based not-for-profit organization, it is estimated that over 4 billion people are expected to be obese by 2035. Therefore, the rise in the increasing obesity rates is driving the growth of the weight loss drugs market.
Major companies operating in the weight loss drug market are developing innovative products such as Zepbound (tirzepatide) injection to better serve patients. Zepbound is a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. For instance, in November 2023, Eli Lilly and Company, a US-based pharmaceutical company received FDA approval for tirzepatide injection (Zepbound) for chronic weight management in adults with overweight or obesity and at least 1 weight-related condition. Zepbound has the potential to be a commercially successful drug, as it is the first and only FDA-approved obesity treatment that activates both GIP and GLP-1 receptors.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13761&type=smp
Major Key Players of the Market:
Pfizer Inc., Roche, Merck & Co., AbbVie Inc., Novartis AG, Bristol Myers Squibb, Sanofi S.A., AstraZeneca plc, LG Chem, GlaxoSmithKline, Takeda Pharmaceutical Company, Eli Lilly and Company, Bayer AG, Amgen Inc., Boehringer Ingelheim group, Novo Nordisk A/S, Merck KGaA, Teva Pharmaceutical Industries Ltd., Hisun Pharmaceutical, Taj Pharmaceuticals Ltd, Zhongshan Pharmaceutical Co. Ltd., Dm Pharma, Lunan Pharmaceutical Group Corporation, Wolfson Berg Ltd., Swiss Research Labs Ltd.
Weight Loss Drugs Market 2024 Key Insights:
• The weight loss drugs market is expected to grow to $12.17 billion in 2028 at a compound annual growth rate (CAGR) of 43.5%.
• Rising Obesity Rates Fueling Surge in the Weight Loss Drugs Market
• Innovative Developments In Weight Loss Drugs Market With Zepbound Approval
• North America was the largest region in the Weight Loss Drugs market in 2023.
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=13761&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Weight Loss Drugs Market Analysis, Size, Growth, Trends And Forecast 2024-2033 here
News-ID: 3678141 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Weight
Weight Loss and Weight Management Diet Market Size - 2034
According to the report by Expert Market Research (EMR), the global weight loss and weight management diet market attained a value of USD 190.35 billion in 2024. Aided by increasing health awareness, growing obesity prevalence, and the adoption of preventive healthcare practices, the market is projected to grow at a CAGR of 8.30% between 2025 and 2034 to reach a value of USD 422.51 billion by 2034.
The weight loss and…
Gemini Weight Loss Candy - Risky Free Candy For Instant Weight Loss!
➣Product Name - Gemini Weight Loss Candy
➣Category - Weight loss
➣Ingredients - Apple Cider Vinegar
➣Benefits - Burn far, Support Skin And Digestion
➣Usage route - Oral Candy
➣Dosage - 1 gummy/day
➣Pricing - $39.97/bottle
➣Side effects - Not reported so far
➣Guarantee - 60-day refund guarantee
➣Where To Buy? - Official Website Only(https://l.linklyhq.com/l/rMzb)
The Gemini Weight Loss Candy is made with Beta-Hydroxybutyrate (BHB). sis is initiated by BHB, which is the first substrate in the genic diet. If…
Massive growth of Preservation Weight Loss and Weight Management Market 2024
Global Weight Loss and Weight Management Market SWOT Analysis And Forecast 2024
Weight Loss and Weight Management has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2019-2024). The research presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data.
Weight Loss and Weight…
Single-Use Sterilization Wraps Market is Segmented By Weights – Light weight, …
Single-Use Sterilization Wraps Market: Overview
The sterilization of surgical equipment helps minimize infections to patients in hospitals. Single-use sterilization wraps are used for wrapping medical devices for sterilization. Single-use sterilization wraps provide protection to medical devices by promoting sterility. Single-use sterilization wraps are used for sequential wrapping technique. Single-use sterilization wraps offer high protection against fluid and particles, are extremely resistant to wear and tear. Single-use sterilization wraps comes with bacterial…
Global Weight Loss and Weight Management Market 2017 : Weight Watchers Internati …
The Market Research Store report offers majority of the latest and newest industry data that covers the overall market situation along with future prospects for Weight Loss and Weight Management market around the globe. The research study includes significant data and also forecasts of the global market which makes the research report a helpful resource for marketing people, analysts, industry executives, consultants, sales and product managers, and other people who…
Global Weight Loss and Weight Management Market Research Report 2016
Global Weight Loss and Weight Management Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020.
The report provides a holistic overview of the global Weight Loss and Weight Management market. It studies the market’s trajectory between 2016 and 2021. Compiling various factors encouraging the market and relevant data summarizing the market’s trajectory in the past few years, the report makes…
